United States Circulating Tumor Cells Market Report 2017

United States Circulating Tumor Cells Market Report 2017

1 Circulating Tumor Cells Overview

1.1 Product Overview and Scope of Circulating Tumor Cells

1.2 Classification of Circulating Tumor Cells by Product Category

1.2.1 United States Circulating Tumor Cells Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Circulating Tumor Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 CTC Enrichment

1.2.4 CTC Detection

1.2.5 CTC Analysis

1.3 United States Circulating Tumor Cells Market by Application/End Users

1.3.1 United States Circulating Tumor Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Prostate Cancer

1.3.3 Breast Cancer

1.3.4 Colorectal Cancer

1.3.5 Others

1.4 United States Circulating Tumor Cells Market by Region

1.4.1 United States Circulating Tumor Cells Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Circulating Tumor Cells Status and Prospect (2012-2022)

1.4.3 Southwest Circulating Tumor Cells Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Circulating Tumor Cells Status and Prospect (2012-2022)

1.4.5 New England Circulating Tumor Cells Status and Prospect (2012-2022)

1.4.6 The South Circulating Tumor Cells Status and Prospect (2012-2022)

1.4.7 The Midwest Circulating Tumor Cells Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Circulating Tumor Cells (2012-2022)

1.5.1 United States Circulating Tumor Cells Sales and Growth Rate (2012-2022)

1.5.2 United States Circulating Tumor Cells Revenue and Growth Rate (2012-2022)

2 United States Circulating Tumor Cells Market Competition by Players/Suppliers

2.1 United States Circulating Tumor Cells Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Circulating Tumor Cells Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Circulating Tumor Cells Average Price by Players/Suppliers (2012-2017)

2.4 United States Circulating Tumor Cells Market Competitive Situation and Trends

2.4.1 United States Circulating Tumor Cells Market Concentration Rate

2.4.2 United States Circulating Tumor Cells Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Circulating Tumor Cells Manufacturing Base Distribution, Sales Area, Product Type

3 United States Circulating Tumor Cells Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Circulating Tumor Cells Sales and Market Share by Region (2012-2017)

3.2 United States Circulating Tumor Cells Revenue and Market Share by Region (2012-2017)

3.3 United States Circulating Tumor Cells Price by Region (2012-2017)

4 United States Circulating Tumor Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Circulating Tumor Cells Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Circulating Tumor Cells Revenue and Market Share by Type (2012-2017)

4.3 United States Circulating Tumor Cells Price by Type (2012-2017)

4.4 United States Circulating Tumor Cells Sales Growth Rate by Type (2012-2017)

5 United States Circulating Tumor Cells Sales (Volume) by Application (2012-2017)

5.1 United States Circulating Tumor Cells Sales and Market Share by Application (2012-2017)

5.2 United States Circulating Tumor Cells Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Circulating Tumor Cells Players/Suppliers Profiles and Sales Data

6.1 Janssen

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Circulating Tumor Cells Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Janssen Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Qiagen?Adnagen?

6.2.2 Circulating Tumor Cells Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Qiagen?Adnagen? Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Acousys Biodevices

6.3.2 Circulating Tumor Cells Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Acousys Biodevices Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 ApoCell

6.4.2 Circulating Tumor Cells Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 ApoCell Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Advanced Cell Diagnostics

6.5.2 Circulating Tumor Cells Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Fluxion Biosciences

6.6.2 Circulating Tumor Cells Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Fluxion Biosciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Biocept

6.7.2 Circulating Tumor Cells Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Biocept Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Fluidigm

6.8.2 Circulating Tumor Cells Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Fluidigm Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Epic Sciences

6.9.2 Circulating Tumor Cells Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Epic Sciences Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Clearbridge Biomedics

6.10.2 Circulating Tumor Cells Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Cynvenio

6.12 CytoTrack

6.13 ScreenCell

6.14 Creatv Microtech

6.15 Aviva Biosciences

6.16 Greiner Bio-one

6.17 Sysmex

6.18 Ikonisys

7 Circulating Tumor Cells Manufacturing Cost Analysis

7.1 Circulating Tumor Cells Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Circulating Tumor Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Circulating Tumor Cells Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Circulating Tumor Cells Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Circulating Tumor Cells Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Circulating Tumor Cells Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Circulating Tumor Cells Sales Volume Forecast by Type (2017-2022)

11.3 United States Circulating Tumor Cells Sales Volume Forecast by Application (2017-2022)

11.4 United States Circulating Tumor Cells Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Circulating Tumor Cells

Figure United States Circulating Tumor Cells Market Size (K Units) by Type (2012-2022)

Figure United States Circulating Tumor Cells Sales Volume Market Share by Type (Product Category) in 2016

Figure CTC Enrichment Product Picture

Figure CTC Detection Product Picture

Figure CTC Analysis Product Picture

Figure United States Circulating Tumor Cells Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Circulating Tumor Cells by Application in 2016

Figure Prostate Cancer Examples

Table Key Downstream Customer in Prostate Cancer

Figure Breast Cancer Examples

Table Key Downstream Customer in Breast Cancer

Figure Colorectal Cancer Examples

Table Key Downstream Customer in Colorectal Cancer

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Circulating Tumor Cells Market Size (Million USD) by Region (2012-2022)

Figure The West Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Circulating Tumor Cells Sales (K Units) and Growth Rate (2012-2022)

Figure United States Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Circulating Tumor Cells Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Circulating Tumor Cells Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Circulating Tumor Cells Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Circulating Tumor Cells Sales Share by Players/Suppliers

Figure 2017 United States Circulating Tumor Cells Sales Share by Players/Suppliers

Figure United States Circulating Tumor Cells Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Circulating Tumor Cells Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Circulating Tumor Cells Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Circulating Tumor Cells Revenue Share by Players/Suppliers

Figure 2017 United States Circulating Tumor Cells Revenue Share by Players/Suppliers

Table United States Market Circulating Tumor Cells Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Circulating Tumor Cells Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Circulating Tumor Cells Market Share of Top 3 Players/Suppliers

Figure United States Circulating Tumor Cells Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Circulating Tumor Cells Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Circulating Tumor Cells Product Category

Table United States Circulating Tumor Cells Sales (K Units) by Region (2012-2017)

Table United States Circulating Tumor Cells Sales Share by Region (2012-2017)

Figure United States Circulating Tumor Cells Sales Share by Region (2012-2017)

Figure United States Circulating Tumor Cells Sales Market Share by Region in 2016

Table United States Circulating Tumor Cells Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Circulating Tumor Cells Revenue Share by Region (2012-2017)

Figure United States Circulating Tumor Cells Revenue Market Share by Region (2012-2017)

Figure United States Circulating Tumor Cells Revenue Market Share by Region in 2016

Table United States Circulating Tumor Cells Price (USD/Unit) by Region (2012-2017)

Table United States Circulating Tumor Cells Sales (K Units) by Type (2012-2017)

Table United States Circulating Tumor Cells Sales Share by Type (2012-2017)

Figure United States Circulating Tumor Cells Sales Share by Type (2012-2017)

Figure United States Circulating Tumor Cells Sales Market Share by Type in 2016

Table United States Circulating Tumor Cells Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Circulating Tumor Cells Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Circulating Tumor Cells by Type (2012-2017)

Figure Revenue Market Share of Circulating Tumor Cells by Type in 2016

Table United States Circulating Tumor Cells Price (USD/Unit) by Types (2012-2017)

Figure United States Circulating Tumor Cells Sales Growth Rate by Type (2012-2017)

Table United States Circulating Tumor Cells Sales (K Units) by Application (2012-2017)

Table United States Circulating Tumor Cells Sales Market Share by Application (2012-2017)

Figure United States Circulating Tumor Cells Sales Market Share by Application (2012-2017)

Figure United States Circulating Tumor Cells Sales Market Share by Application in 2016

Table United States Circulating Tumor Cells Sales Growth Rate by Application (2012-2017)

Figure United States Circulating Tumor Cells Sales Growth Rate by Application (2012-2017)

Table Janssen Basic Information List

Table Janssen Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Janssen Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Janssen Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Janssen Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Qiagen?Adnagen? Basic Information List

Table Qiagen?Adnagen? Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Qiagen?Adnagen? Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Qiagen?Adnagen? Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Qiagen?Adnagen? Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Acousys Biodevices Basic Information List

Table Acousys Biodevices Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Acousys Biodevices Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Acousys Biodevices Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Acousys Biodevices Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table ApoCell Basic Information List

Table ApoCell Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure ApoCell Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure ApoCell Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure ApoCell Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Advanced Cell Diagnostics Basic Information List

Table Advanced Cell Diagnostics Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Advanced Cell Diagnostics Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Advanced Cell Diagnostics Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Advanced Cell Diagnostics Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Fluxion Biosciences Basic Information List

Table Fluxion Biosciences Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Fluxion Biosciences Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Fluxion Biosciences Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Fluxion Biosciences Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Biocept Basic Information List

Table Biocept Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Biocept Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Biocept Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Biocept Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Fluidigm Basic Information List

Table Fluidigm Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Fluidigm Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Fluidigm Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Fluidigm Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Epic Sciences Basic Information List

Table Epic Sciences Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Epic Sciences Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Epic Sciences Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Epic Sciences Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Clearbridge Biomedics Basic Information List

Table Clearbridge Biomedics Circulating Tumor Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Clearbridge Biomedics Circulating Tumor Cells Sales Growth Rate (2012-2017)

Figure Clearbridge Biomedics Circulating Tumor Cells Sales Market Share in United States (2012-2017)

Figure Clearbridge Biomedics Circulating Tumor Cells Revenue Market Share in United States (2012-2017)

Table Cynvenio Basic Information List

Table CytoTrack Basic Information List

Table ScreenCell Basic Information List

Table Creatv Microtech Basic Information List

Table Aviva Biosciences Basic Information List

Table Greiner Bio-one Basic Information List

Table Sysmex Basic Information List

Table Ikonisys Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Circulating Tumor Cells

Figure Manufacturing Process Analysis of Circulating Tumor Cells

Figure Circulating Tumor Cells Industrial Chain Analysis

Table Raw Materials Sources of Circulating Tumor Cells Major Players/Suppliers in 2016

Table Major Buyers of Circulating Tumor Cells

Table Distributors/Traders List

Figure United States Circulating Tumor Cells Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Circulating Tumor Cells Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Type in 2022

Table United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Application in 2022

Table United States Circulating Tumor Cells Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Circulating Tumor Cells Sales Volume Share Forecast by Region (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume Share Forecast by Region (2017-2022)

Figure United States Circulating Tumor Cells Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources